141 related articles for article (PubMed ID: 12151077)
1. High performance liquid chromatography for routine monitoring of serum flecainide.
Nakagawa R; Homma M; Kuga K; Yamaguchi I; Kobayashi D; Morimoto Y; Kohda Y
J Pharm Biomed Anal; 2002 Aug; 30(1):171-4. PubMed ID: 12151077
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography.
Doki K; Homma M; Kuga K; Watanabe S; Yamaguchi I; Kohda Y
J Pharm Biomed Anal; 2004 Sep; 35(5):1307-12. PubMed ID: 15336377
[TBL] [Abstract][Full Text] [Related]
3. Determination of concentrations of flecainide in human serum by high-performance liquid chromatography on a fluorocarbon-bonded silica gel column.
Obayashi M; Kosugi T; Yamazaki J; Matsumoto Y; Fukuoka M; Matsumoto M
J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):219-23. PubMed ID: 10348189
[TBL] [Abstract][Full Text] [Related]
4. Measurement of flecainide plasma concentrations by high performance liquid chromatography with fluorescence detection.
Plomp TA; Boom HT; Maes RA
J Anal Toxicol; 1986; 10(3):102-6. PubMed ID: 3724068
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of flecainide in serum using high-performance liquid chromatography and electrospray mass spectrometry.
Breindahl T
J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(2):249-54. PubMed ID: 11076078
[TBL] [Abstract][Full Text] [Related]
6. A high performance liquid chromatographic method for the quantitation of flecainide in plasma.
Broly F; Marecaux P; Houdret N; Lhermitte M; Houssin R
Biomed Chromatogr; 1991 Nov; 5(6):248-50. PubMed ID: 1760591
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatographic determination of unbound flecainide in therapeutic drug monitoring.
Katori K; Homma M; Kuga K; Yamaguchi I; Sugibayashi K; Kohda Y
J Pharm Biomed Anal; 2003 Jun; 32(2):375-80. PubMed ID: 12763549
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatographic determination of plasma ropivacaine for assessing pharmacokinetics of the viscous preparation.
Kawata T; Homma M; Kakiuchi Y; Inomata S; Miyabe M; Kobayashi D; Morimoto Y; Kohda Y
Biol Pharm Bull; 2005 Dec; 28(12):2271-3. PubMed ID: 16327164
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective analysis of flecainide enantiomers using reversed-phase liquid chromatography for assessing CYP2D6 activity.
Doki K; Sekiguchi Y; Kuga K; Aonuma K; Kohda Y; Homma M
Biomed Chromatogr; 2014 Sep; 28(9):1193-8. PubMed ID: 24523024
[TBL] [Abstract][Full Text] [Related]
10. Validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of flecainide in human plasma and its clinical application.
Mano Y; Asakawa Y; Kita K; Ishii T; Hotta K; Kusano K
Biomed Chromatogr; 2015 Sep; 29(9):1399-405. PubMed ID: 25641720
[TBL] [Abstract][Full Text] [Related]
11. Improved solid-phase extraction technique for plasma flecainide analysis by high-performance liquid chromatography.
Wilson KM; Schneider JJ; Ravenscroft PJ
Ther Drug Monit; 1998 Aug; 20(4):435-8. PubMed ID: 9712470
[TBL] [Abstract][Full Text] [Related]
12. A simple HPLC assay for determining eltrombopag concentration in human serum.
Yanagimachi N; Obara N; Sakata-Yanagimoto M; Chiba S; Doki K; Homma M
Biomed Chromatogr; 2021 May; 35(5):e5049. PubMed ID: 33314287
[TBL] [Abstract][Full Text] [Related]
13. A simple high-performance liquid chromatographic method for the routine measurement of flecainide in plasma.
Grgurinovich N
J Anal Toxicol; 1988; 12(1):38-41. PubMed ID: 3127637
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic determination of the enantiomers of flecainide in human plasma and urine.
Alessi-Severini S; Jamali F; Pasutto FM; Coutts RT; Gulamhusein S
J Pharm Sci; 1990 Mar; 79(3):257-60. PubMed ID: 2110973
[TBL] [Abstract][Full Text] [Related]
15. A rapid HPLC method for the determination of losartan in human plasma using a monolithic column.
Zarghi A; Foroutan SM; Shafaati A; Khoddam A
Arzneimittelforschung; 2005; 55(10):569-72. PubMed ID: 16294502
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic method for the quantitation of flecainide, a new antiarrhythmic, in human plasma and urine.
Chang SF; Welscher TM; Miller AM; Ober RE
J Chromatogr; 1983 Feb; 272(2):341-50. PubMed ID: 6833431
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of serum propafenone and its metabolites using high-performance liquid chromatography.
Shirayama Y; Doki K; Sekiguchi Y; Aonuma K; Kohda Y; Homma M
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28929504
[TBL] [Abstract][Full Text] [Related]
18. Application of a bonded-phase extraction column for rapid sample preparation of flecainide from human plasma for high-performance liquid chromatographic analysis--fluorescence or ultraviolet detection.
Chang SF; Miller AM; Fox JM; Welscher TM
Ther Drug Monit; 1984; 6(1):105-11. PubMed ID: 6710553
[TBL] [Abstract][Full Text] [Related]
19. Assessment of serum flecainide trough levels in patients with tachyarrhythmia.
Homma M; Kuga K; Doki K; Katori K; Yamaguchi I; Sugibayashi K; Kohda Y
J Pharm Pharmacol; 2005 Jan; 57(1):47-51. PubMed ID: 15638992
[TBL] [Abstract][Full Text] [Related]
20. Assay of flecainide in serum by high-performance liquid chromatography after microscale protein precipitation.
Malikin G; Murphy M; Lam S
Ther Drug Monit; 1989; 11(2):210-3. PubMed ID: 2497564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
